Tau‐PET imaging in Progressive Supranuclear Palsy and relationship with biomarkers and clinical markers
Roxane Dilcher, Charles B Malpas, Terence J O'Brien, Lucy Vivash · 2025
Read Tau‐PET imaging in Progressive Supranuclear Palsy and relationship with biomarkers and clinical markers by Roxane Dilcher, Charles B Malpas, Terence J O'Brien, Lucy Vivash (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712587.txt.
Description
Roxane Dilcher and co-authors scanned tau buildup in progressive supranuclear palsy in a 2025 study. This palsy is a tau disease that stiffens movement and gaze, and it lacks a firm biomarker. A newer PET tracer, 18F-PI-2620, can light up tau in the living brain.
The team studied 20 patients with the likely form of the disease. Each had a brain scan set: MRI, the tau PET, a spinal fluid tap, and blood tests. Tracer binding was then set against clinic scores and the other markers. A scan that tracks disease weight could sharpen diagnosis and drug trials.
Catalog record
| CREATOR | Roxane Dilcher, Charles B Malpas, Terence J O'Brien, Lucy Vivash |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |